Alzheimer's disease & dementia

New drug targets early instigator of Alzheimer's disease

Over a hundred years after they were first identified, two ominous signposts of Alzheimer's disease (AD) remain central topics of research—both formed by sticky accumulations of protein in the brain. Amyloid beta solidifies ...

Alzheimer's disease & dementia

New Alzheimer's drug to enter clinical trials

A new drug developed at Lancaster University in the UK that may help to prevent the early stages of Alzheimer's disease is to enter clinical trials.

Alzheimer's disease & dementia

What can beagles teach us about Alzheimer's disease?

Every 67 seconds someone in the United States is diagnosed with Alzheimer's disease and new estimates suggest that it may be the third leading cause of death of older people.

Medical research

Prion-like proteins drive several diseases of aging

Two leading neurology researchers have proposed a theory that could unify scientists' thinking about several neurodegenerative diseases and suggest therapeutic strategies to combat them.

Alzheimer's disease & dementia

Major step toward an Alzheimer's vaccine

A team of researchers from Université Laval, CHU de Québec, and pharmaceutical firm GlaxoSmithKline (GSK) has discovered a way to stimulate the brain's natural defense mechanisms in people with Alzheimer's disease. This ...

page 1 from 2